135376-89-5

Upstream product

• 78715-56-7 tetraethyl fluoromethylenebisphosphonate 
• 98510-27-1 (8S,9R)-8,9-Bis-benzyloxy-2,4,10-trioxa-tricyclo[3.3.1.1^3,7]decan-6-one 
• 100-39-0 benzyl bromide 
• 98510-20-4 myo-inositol monoorthoformate 
• 98510-25-9 (6S,8R,9S)-8,9-Bis-benzyloxy-2,4,10-trioxa-tricyclo[3.3.1.1^3,7]decan-6-ol 

Downstream Products

• 135346-04-2 (3aS,4R,5S,6R,7S,7aS)-3-Fluoro-2-oxo-octahydro-2λ⁵-benzo[d][1,2]oxaphosphole-2,4,5,6,7-pentaol 
• 135346-05-3 [Fluoro-((1S,2R,3S,4R,5R,6S)-2,3,4,5,6-pentahydroxy-cyclohexyl)-methyl]-phosphonic acid 
• 135415-09-7 [Fluoro-((1R,2S,3R,4R,5S,6R)-2,3,4,5,6-pentahydroxy-cyclohexyl)-methyl]-phosphonic acid 

Relevant academic research and scientific papers

Synthesis of an analogue of D,L-MYO-inositol-1,2-cyclic phosphate: Inhibition of phosphatidylinositol-specific phospholipase C

A fluorophosphonate analogue of myo-inositol-1,2-cyclic phosphate (cIP) has been synthesized: the specific, potent inhibition of a phosphatidyl inositol-specific phospholipase C (PI-PLC) by this compound is compared with inhibition by vanadate ion.